Adynxx, Inc. (New). (ALQA) NASDAQ
- - (-)
Market Cap: -
As of 12/05/23 04:00 PM EST. Market closed.
Adynxx, Inc. (New). (ALQA)
NASDAQ
-
- (-)
Market Cap: -
As of 12/05/23 04:00 PM EST. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Health Technology
Industry
Pharmaceuticals: Major
PRICE CHART FOR ADYNXX, INC. (NEW)
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$0.45
Days Range
- - -
52 week range
$7.36 - $31.44
Volume
0
Avg. Volume (30 days)
18,760
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$0.45
Days Range
- - -
52 week range
$7.36 - $31.44
Volume
0
Avg. Volume (30 days)
18,760
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR ADYNXX, INC. (NEW)
LOADING...
INSIDER TRANSACTIONS FOR ADYNXX, INC. (NEW)
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
BARTON BRADFORD | Chief Operating Officer | Sep 21, 2017 | Option Exercise | $0.42 | 67,536 | 28,365 | 558,822 | Sep 25, 2017, 04:41 PM |
POSNER BRIAN M | Chief Financial Officer | Sep 21, 2017 | Option Exercise | $0.42 | 70,833 | 29,750 | 476,421 | Sep 25, 2017, 04:20 PM |
Pionati Pellegrino | See Remarks | Sep 21, 2017 | Option Exercise | $0.42 | 69,978 | 29,391 | 506,601 | Sep 25, 2017, 04:11 PM |
Pionati Pellegrino | See Remarks | Jun 15, 2017 | Option Exercise | $0.37 | 10,032 | 3,712 | 270,864 | Jun 21, 2017, 05:30 PM |
WAGNER MARK T | Director | Mar 21, 2017 | Option Exercise | $0.67 | 75,876 | 50,837 | 323,802 | Apr 04, 2017, 09:05 AM |
WAGNER MARK T | Director | Apr 03, 2017 | Buy | $0.40 | 62,500 | 25,000 | 70,500 | Apr 04, 2017, 09:05 AM |
BARTON BRADFORD | Chief Operating Officer | Apr 03, 2017 | Buy | $0.40 | 75,000 | 30,000 | 320,643 | Apr 04, 2017, 09:04 AM |
LEONE JOSEPH M | Director | Apr 03, 2017 | Buy | $0.40 | 25,000 | 10,000 | 43,823 | Apr 04, 2017, 09:02 AM |
Pionati Pellegrino | See Remarks | Apr 03, 2017 | Buy | $0.40 | 50,000 | 20,000 | 280,896 | Apr 04, 2017, 09:02 AM |
Johnson David Ian | President and CEO | Apr 03, 2017 | Buy | $0.40 | 250,000 | 100,000 | 1,194,535 | Apr 04, 2017, 09:00 AM |
ZELDIS JEROME B | Director | Feb 27, 2017 | Buy | $0.50 | 400,000 | 200,000 | 686,750 | Mar 01, 2017, 06:04 AM |
WAGNER MARK T | Director | Mar 16, 2016 | Option Exercise | $2.61 | 73,893 | 192,861 | 247,926 | May 20, 2016, 03:29 PM |
Sklar Jeffrey | Director | Nov 06, 2015 | Buy | $2.95 | 1,500 | 4,425 | 24,357 | Nov 12, 2015, 08:41 AM |
POSNER BRIAN M | Chief Financial Officer | Nov 09, 2015 | Buy | $3.04 | 5,000 | 15,200 | 116,881 | Nov 10, 2015, 10:53 AM |
BARTON BRADFORD | Chief Operating Officer | Nov 06, 2015 | Buy | $2.97 | 5,000 | 14,850 | 120,985 | Nov 09, 2015, 03:08 PM |
Johnson David Ian | President and CEO | Nov 06, 2015 | Buy | $2.92 | 8,650 | 25,258 | 584,603 | Nov 09, 2015, 12:04 PM |
LEONE JOSEPH M | Director | Nov 06, 2015 | Buy | $2.78 | 3,500 | 9,730 | 18,823 | Nov 09, 2015, 12:00 PM |
WAGNER MARK T | Director | Nov 06, 2015 | Buy | $2.88 | 8,000 | 23,040 | 8,000 | Nov 09, 2015, 11:58 AM |
ZELDIS JEROME B | Director | Nov 06, 2015 | Buy | $2.91 | 14,000 | 40,740 | 286,750 | Nov 09, 2015, 11:55 AM |
Pionati Pellegrino | Chief Strategy & Marketing Off | Nov 06, 2015 | Buy | $2.95 | 10,000 | 29,500 | 116,512 | Nov 09, 2015, 11:50 AM |
POSNER BRIAN M | Chief Financial Officer | Aug 10, 2015 | Buy | $5.02 | 2,500 | 12,550 | 111,881 | Aug 10, 2015, 11:47 AM |
Johnson David Ian | President and CEO | Jul 01, 2015 | Option Exercise | $5.35 | 19,191 | 102,672 | 575,953 | Jul 06, 2015, 04:15 PM |
Pionati Pellegrino | See Remarks | Jun 15, 2015 | Option Exercise | $5.25 | 13,488 | 70,812 | 106,512 | Jun 17, 2015, 04:06 PM |
BARTON BRADFORD | Chief Operating Officer | Jun 08, 2015 | Buy | $5.24 | 3,000 | 15,735 | 115,985 | Jun 10, 2015, 10:00 AM |
Johnson David Ian | President and CEO | May 27, 2015 | Buy | $4.65 | 10,000 | 46,458 | 595,144 | May 28, 2015, 02:02 PM |
POSNER BRIAN M | Chief Financial Officer | May 20, 2015 | Buy | $4.34 | 2,500 | 10,850 | 109,381 | May 20, 2015, 11:41 AM |
CELGENE CORP /DE/ | 10% Owner | May 04, 2015 | Buy | $4.55 | 659,340 | 2,999,997 | 3,046,100 | May 04, 2015, 04:19 PM |
Johnson David Ian | President and CEO | Apr 01, 2015 | Option Exercise | $5.19 | 20,590 | 106,862 | 585,144 | Apr 03, 2015, 04:28 PM |
Johnson David Ian | President and CEO | Mar 06, 2015 | Option Exercise | $5.29 | 7,673 | 40,590 | 605,734 | Mar 10, 2015, 04:25 PM |
POSNER BRIAN M | Chief Financial Officer | Mar 06, 2015 | Option Exercise | $5.29 | 759 | 4,015 | 106,881 | Mar 10, 2015, 04:24 PM |
BARTON BRADFORD | Chief Operating Officer | Mar 06, 2015 | Option Exercise | $5.29 | 2,225 | 11,770 | 112,985 | Mar 10, 2015, 04:24 PM |
Johnson David Ian | President and CEO | Jan 01, 2015 | Option Exercise | $5.30 | 21,681 | 114,909 | 313,407 | Jan 05, 2015, 05:28 PM |
Johnson David Ian | President and CEO | Oct 01, 2014 | Option Exercise | $4.84 | 20,552 | 99,472 | 335,088 | Oct 02, 2014, 11:56 AM |
POSNER BRIAN M | Chief Financial Officer | Sep 15, 2014 | Buy | $4.94 | 2,000 | 9,880 | 7,640 | Sep 16, 2014, 12:33 PM |
ZELDIS JEROME B | Director | Sep 03, 2014 | Option Exercise | $4.24 | 23,500 | 99,640 | 272,750 | Sep 04, 2014, 11:50 AM |
Johnson David Ian | President and CEO | Jul 01, 2014 | Option Exercise | $5.74 | 20,367 | 116,907 | 355,640 | Jul 14, 2014, 10:09 AM |
ZELDIS JEROME B | Director | Jun 06, 2014 | Option Exercise | $4.24 | 23,500 | 99,640 | 249,250 | Jun 10, 2014, 02:18 PM |
POSNER BRIAN M | Chief Financial Officer | May 13, 2014 | Buy | $6.92 | 3,000 | 20,760 | 5,640 | May 13, 2014, 11:41 AM |
CELGENE CORP /DE/ | 10% Owner | Apr 14, 2014 | Buy | $7.00 | 714,286 | 5,000,002 | 2,386,760 | Apr 15, 2014, 04:01 PM |
Johnson David Ian | President and CEO | Apr 01, 2014 | Option Exercise | $8.25 | 20,186 | 166,535 | 376,007 | Apr 03, 2014, 07:56 PM |
SAPIRSTEIN JAMES | CEO, Therapeutics Division | Jan 09, 2014 | Option Exercise | $8.18 | 7,104 | 58,111 | 31,662 | Jan 17, 2014, 04:40 PM |
Johnson David Ian | President and CEO | Jan 06, 2014 | Option Exercise | $6.99 | 19,245 | 134,523 | 378,369 | Jan 08, 2014, 09:10 PM |
SAPIRSTEIN JAMES | CEO, Alliqua Biomedical, Inc. | Nov 27, 2013 | Option Exercise | $4.46 | 14,299 | 63,774 | 21,078 | Dec 23, 2013, 06:00 PM |
LONDONER KENNETH L | Director | May 21, 2013 | Buy | $0.07 | 38,500 | 2,695 | 1,859,500 | May 23, 2013, 03:21 PM |
LONDONER KENNETH L | Director | May 20, 2013 | Buy | $0.07 | 181,000 | 12,364 | 1,821,000 | May 23, 2013, 03:21 PM |
Kalen Capital Corp | 10% Owner | Mar 28, 2012 | Sale | $0.04 | 24,057,980 | 962,319 | 0 | Mar 29, 2012, 02:07 PM |
Sklar Jeffrey | Director | Jun 02, 2011 | Buy | $0.11 | 30,000 | 3,300 | 280,000 | Jun 06, 2011, 04:18 PM |
1420525 ALBERTA LTD. | 10% Owner | Oct 21, 2009 | Option Exercise | $0.15 | 1,032,706 | 154,906 | 31,057,980 | Apr 04, 2011, 05:49 PM |
1420525 ALBERTA LTD. | 10% Owner | Mar 30, 2011 | Option Exercise | $0.05 | 7,000,000 | 350,000 | 24,057,980 | Apr 04, 2011, 05:49 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
BARTON BRADFORD | Chief Operating Officer | 09/21/2017 | 28,365 |
POSNER BRIAN M | Chief Financial Officer | 09/21/2017 | 29,750 |
Pionati Pellegrino | See Remarks | 09/21/2017 | 29,391 |
Pionati Pellegrino | See Remarks | 06/15/2017 | 3,712 |
WAGNER MARK T | Director | 03/21/2017 | 50,837 |
WAGNER MARK T | Director | 04/03/2017 | 25,000 |
BARTON BRADFORD | Chief Operating Officer | 04/03/2017 | 30,000 |
LEONE JOSEPH M | Director | 04/03/2017 | 10,000 |
Pionati Pellegrino | See Remarks | 04/03/2017 | 20,000 |
Johnson David Ian | President and CEO | 04/03/2017 | 100,000 |
ZELDIS JEROME B | Director | 02/27/2017 | 200,000 |
WAGNER MARK T | Director | 03/16/2016 | 192,861 |
Sklar Jeffrey | Director | 11/06/2015 | 4,425 |
POSNER BRIAN M | Chief Financial Officer | 11/09/2015 | 15,200 |
BARTON BRADFORD | Chief Operating Officer | 11/06/2015 | 14,850 |
Johnson David Ian | President and CEO | 11/06/2015 | 25,258 |
LEONE JOSEPH M | Director | 11/06/2015 | 9,730 |
WAGNER MARK T | Director | 11/06/2015 | 23,040 |
ZELDIS JEROME B | Director | 11/06/2015 | 40,740 |
Pionati Pellegrino | Chief Strategy & Marketing Off | 11/06/2015 | 29,500 |
POSNER BRIAN M | Chief Financial Officer | 08/10/2015 | 12,550 |
Johnson David Ian | President and CEO | 07/01/2015 | 102,672 |
Pionati Pellegrino | See Remarks | 06/15/2015 | 70,812 |
BARTON BRADFORD | Chief Operating Officer | 06/08/2015 | 15,735 |
Johnson David Ian | President and CEO | 05/27/2015 | 46,458 |
POSNER BRIAN M | Chief Financial Officer | 05/20/2015 | 10,850 |
CELGENE CORP /DE/ | 10% Owner | 05/04/2015 | 2,999,997 |
Johnson David Ian | President and CEO | 04/01/2015 | 106,862 |
Johnson David Ian | President and CEO | 03/06/2015 | 40,590 |
POSNER BRIAN M | Chief Financial Officer | 03/06/2015 | 4,015 |
BARTON BRADFORD | Chief Operating Officer | 03/06/2015 | 11,770 |
Johnson David Ian | President and CEO | 01/01/2015 | 114,909 |
Johnson David Ian | President and CEO | 10/01/2014 | 99,472 |
POSNER BRIAN M | Chief Financial Officer | 09/15/2014 | 9,880 |
ZELDIS JEROME B | Director | 09/03/2014 | 99,640 |
Johnson David Ian | President and CEO | 07/01/2014 | 116,907 |
ZELDIS JEROME B | Director | 06/06/2014 | 99,640 |
POSNER BRIAN M | Chief Financial Officer | 05/13/2014 | 20,760 |
CELGENE CORP /DE/ | 10% Owner | 04/14/2014 | 5,000,002 |
Johnson David Ian | President and CEO | 04/01/2014 | 166,535 |
SAPIRSTEIN JAMES | CEO, Therapeutics Division | 01/09/2014 | 58,111 |
Johnson David Ian | President and CEO | 01/06/2014 | 134,523 |
SAPIRSTEIN JAMES | CEO, Alliqua Biomedical, Inc. | 11/27/2013 | 63,774 |
LONDONER KENNETH L | Director | 05/21/2013 | 2,695 |
LONDONER KENNETH L | Director | 05/20/2013 | 12,364 |
Kalen Capital Corp | 10% Owner | 03/28/2012 | 962,319 |
Sklar Jeffrey | Director | 06/02/2011 | 3,300 |
1420525 ALBERTA LTD. | 10% Owner | 10/21/2009 | 154,906 |
1420525 ALBERTA LTD. | 10% Owner | 03/30/2011 | 350,000 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR ADYNXX, INC. (NEW)
LOADING...